Unique ID issued by UMIN | UMIN000028284 |
---|---|
Receipt number | R000032379 |
Scientific Title | A minimally invasive test for diagnosis of pancreatic neoplasm using cell-free nucleic acid and residual specimens |
Date of disclosure of the study information | 2017/07/19 |
Last modified on | 2023/04/05 15:43:05 |
A minimally invasive test for
diagnosis of pancreatic neoplasm
using cell-free nucleic acid and residual specimens
A minimally invasive test for
diagnosis of pancreatic neoplasm
A minimally invasive test for
diagnosis of pancreatic neoplasm
using cell-free nucleic acid and residual specimens
A minimally invasive test for
diagnosis of pancreatic neoplasm
Japan |
Patients with pancreatic cancer and
its precancerous lesions, and
individuals at high risk of developing
pancreatic neoplasm, and patients
with benign gastrointestinal
disorders such as cholelithiasis and
gastroduodenal ulcer
Hepato-biliary-pancreatic medicine | Gastrointestinal surgery |
Malignancy
YES
To examine the efficacy and
feasibility of the quantitative
detection of tumor-associated nucleic
acid in the body fluid, including blood
and pancreatic juice collected from the duodenum,
and residual tissue specimens for
diagnosis of pancreatic neoplasm.
Efficacy
Exploratory
Pragmatic
Not applicable
Diagnostic value of quantitative
detection and monitoring of
tumor-associated alterations
in circulating cell-free nucleic acid
and tissue-derived nucleic acid
for the diagnosis of pancreatic neoplasm.
Surveillance of individuals at high
risk of developing pancreatic
neoplasm by quantitative detection
and monitoring of tumor-associated
alterations in cell-free nucleic
acid and tissue-derived nucleic acid.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
・Patients with malignant pancreatic tumor
and benign/pre-cancerous lesions.
・Individuals at high risk of developing
pancreatic neoplasm.
・Patients with benign digestive disorder
who receive upper endoscopic examination.
・Patients with written informed consent.
・Patients with severe heart disease
・Patients with severe renal disease
・Patients with serious mental illness
・Patients complicated with severe
infection
・Patients with severe diabetes
・Patients with severe dehydration
and malnutrition
・Patients who have other serious
complications and are considered
difficult to participate
・Patient who judged inappropriate
by an attendant physician
400
1st name | Yusuke |
Middle name | |
Last name | Mizukami |
Asahikawa Medical University
Cancer Genomics and Precision Medicine Department of Medicine
0788510
2-1 Midorigaoka Higashi, Asahikawa,Hokkaido 078-8510
0166-68-2462
mizu@asahikawa-med.ac.jp
1st name | Yusuke |
Middle name | |
Last name | Mizukami |
Asahikawa Medical University
Cancer Genomics and Precision Medicine Department of Medicine
0788510
2-1 Midorigaoka Higashi, Asahikawa,Hokkaido 078-8510
0166-68-2462
mizu@asahikawa-med.ac.jp
Asahikawa Medical University
Hitachi High-Tech Corporation
Other
Sapporo Higashi Tokushukai Hospital
Asahikawa-Kosei General Hospital
Japanese Red Cross Asahikawa Hospital
Shibetsu City Hospital
Teine Keijinkai Hospital
Engaru-Kosei General Hospital
Hitachi High-Tech Corporation
N/A
N/A
N/A
N/A
NO
旭川医科大学(北海道)
2017 | Year | 07 | Month | 19 | Day |
Unpublished
Completed
2017 | Year | 06 | Month | 08 | Day |
2022 | Year | 11 | Month | 29 | Day |
2017 | Year | 06 | Month | 20 | Day |
2022 | Year | 03 | Month | 31 | Day |
None
2017 | Year | 07 | Month | 19 | Day |
2023 | Year | 04 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032379
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |